40
HLA Genetics Consortium Meeting, December 14-15, 2010

Representation and Use of Clinical Data in Immport

  • Upload
    les

  • View
    29

  • Download
    0

Embed Size (px)

DESCRIPTION

Representation and Use of Clinical Data in Immport. David Karp, M.D., Ph.D. Richard Scheuermann, Ph.D. General Thoughts Regarding Clinical Data. Please make sure any prospectively collected data used consent forms that take data sharing into account. Other researchers NIH De-identified - PowerPoint PPT Presentation

Citation preview

Page 1: Representation and Use of Clinical Data in Immport

HLA Genetics Consortium Meeting, December 14-15, 2010

Page 2: Representation and Use of Clinical Data in Immport

HLA region genomics consortium

Representation and Use of Clinical Data in Immport

David Karp, M.D., Ph.D.Richard Scheuermann, Ph.D.

Page 3: Representation and Use of Clinical Data in Immport

HLA Genetics Consortium Meeting, December 14-15, 2010

General Thoughts Regarding Clinical Data

Please make sure any prospectively collected data used consent forms that take data sharing into account. Other researchers NIH De-identified

No Protected Healthcare Information is displayed. E.g., dates are converted to study times

Genetic data such as SNP haplotypes or frequencies are not part of the Semi-Public Workspace.

Page 4: Representation and Use of Clinical Data in Immport

HLA Genetics Consortium Meeting, December 14-15, 2010

Levels of Clinical Data

Simple – Subject demographics and phenotype Can use built-in data submission templates (Excel)

Complex – Clinical measurements, time course Vital signs CBC Chemistry Serologies Response to vaccination Pulmonary function tests BASDI, BASFI, Rodnan Skin Score, etc.

Page 5: Representation and Use of Clinical Data in Immport

HLA Genetics Consortium Meeting, December 14-15, 2010

Submitting Clinical Data

Investigator controls data during loading Give BISC team (Meagan Kong, Ph.D.) a data dictionary,

protocol, and database schema We create map from your data to our data model You generate the load file More time-consuming on your part

Investigator gives data to BISC for loading BISC team creates data maps and load files Investigator can then validate the data integrity

Neither method is easy to do incrementally – best to have all data loaded at once

Page 6: Representation and Use of Clinical Data in Immport

HLA Genetics Consortium Meeting, December 14-15, 2010

Standard Subject Templates

Page 7: Representation and Use of Clinical Data in Immport

HLA Genetics Consortium Meeting, December 14-15, 2010

ImmPort Data Templates

Page 8: Representation and Use of Clinical Data in Immport

HLA Genetics Consortium Meeting, December 14-15, 2010

Content of Study Design Workbook

StudyInterventional ParametersObservational ParametersInclusion Exclusion

Arm or CohortPeriodEvent PlanVisit PlanVisit to ArmEvent PanelEvent Panel components

SiteStudy Personnel

Subject Measure DefinitionsOutcome Measure Definitions

Glossary

Page 9: Representation and Use of Clinical Data in Immport

HLA Genetics Consortium Meeting, December 14-15, 2010

Cartoon Representation of ImmPort Study Schema

StudyTitleObjectivesDescription…

ARM_or_COHORTArm_NameNameDescription…

PLANNED_VISITVisit_Order_NumberVisit_Name…

PLANNED_EVENTEvent_Name_Reported…

PERIODTitleOrder_number…

VISIT_2_ARM

PLANNED_EVENT_2_EVENT_PANEL

EVENT_PANELUser_Def_Event_Panel_IDEvent_Panel_Desc…

EVENT_PANEL_COMPONENTSComponent_Order_NumComponent_Desc…

INTERVENTIONAL_PARAMETERSPrimary_PurposeStudy_Phase…

OUTCOME_MEASURE_DEFINTIONAnalysisPopDescOutcomeType…

OBSERVATIONAL_PARAMETERSObservation_ModelTime_perspective…

SUBJECT_MEASURE_DEFINTIONOutcomeTypeMeasureType…

POPULATION_SELECTION_RULEPopulation_NameDesc…

SITESite_Name…

STUDY_PERSONNELLast_NameFirst_Name…

STUDY_PERSONNEL_2_SITE

GLOSSARYTermDefinition…

INclUSION_EXCLUSIONCriterion_NameCriterion_Category…

Nov 2009

Page 10: Representation and Use of Clinical Data in Immport

HLA Genetics Consortium Meeting, December 14-15, 2010

Study Design Workbook

Study

Arm or Cohort

Period

Event Plan

Visit Plan

Page 11: Representation and Use of Clinical Data in Immport

HLA Genetics Consortium Meeting, December 14-15, 2010

Study Design Workbook

Observational parameters

Interventional Parameters

Subject Measure Definitions

Dropdown Menus

Comments

Page 12: Representation and Use of Clinical Data in Immport

HLA Genetics Consortium Meeting, December 14-15, 2010

Case Report Form Data Templates Content

Biosampling (e.g., Blood draw)Substance Merge (e.g., Medication)Assessment (e.g., Medical History)Lab test Reference RangeAdverse EventEarly TerminationProtocol DeviationActual Visit

Subject Measure ResultsLab Test (panel ) Derived Results

Arm or Cohort to SubjectBiosampling to Biological SamplesStudy to Protocol

Page 13: Representation and Use of Clinical Data in Immport

HLA Genetics Consortium Meeting, December 14-15, 2010

Case Report Form Data Templates

Assessment (e.g., Medical History, Family History, Vital Signs)

Biosampling

Lab Test

Page 14: Representation and Use of Clinical Data in Immport

HLA Genetics Consortium Meeting, December 14-15, 2010

Case Report Form Data Submission

Mapping File Generation

Page 15: Representation and Use of Clinical Data in Immport

HLA Genetics Consortium Meeting, December 14-15, 2010

Experiment (Mechanistic Assay)

SUBJECTNameDescription…

BIOLOGICAL SAMPLENameDescription…

EXPERIMENT_SAMPLENameDescription…

EXPERIMENTNameDescription…

PROTOCOLNameDescription…

Assay ResultsNameDescription…

REAGENTNameDescription…

Page 16: Representation and Use of Clinical Data in Immport

HLA Genetics Consortium Meeting, December 14-15, 2010

Page 17: Representation and Use of Clinical Data in Immport

HLA Genetics Consortium Meeting, December 14-15, 2010

Page 18: Representation and Use of Clinical Data in Immport

HLA Genetics Consortium Meeting, December 14-15, 2010

Page 19: Representation and Use of Clinical Data in Immport

HLA Genetics Consortium Meeting, December 14-15, 2010

Page 20: Representation and Use of Clinical Data in Immport

HLA Genetics Consortium Meeting, December 14-15, 2010

Page 21: Representation and Use of Clinical Data in Immport

HLA Genetics Consortium Meeting, December 14-15, 2010

Page 22: Representation and Use of Clinical Data in Immport

HLA Genetics Consortium Meeting, December 14-15, 2010

Page 23: Representation and Use of Clinical Data in Immport

HLA Genetics Consortium Meeting, December 14-15, 2010

Page 24: Representation and Use of Clinical Data in Immport

HLA Genetics Consortium Meeting, December 14-15, 2010

Page 25: Representation and Use of Clinical Data in Immport

HLA Genetics Consortium Meeting, December 14-15, 2010

Page 26: Representation and Use of Clinical Data in Immport

HLA Genetics Consortium Meeting, December 14-15, 2010

Page 27: Representation and Use of Clinical Data in Immport

HLA Genetics Consortium Meeting, December 14-15, 2010

Page 28: Representation and Use of Clinical Data in Immport

HLA Genetics Consortium Meeting, December 14-15, 2010

Page 29: Representation and Use of Clinical Data in Immport

HLA Genetics Consortium Meeting, December 14-15, 2010

Page 30: Representation and Use of Clinical Data in Immport

HLA Genetics Consortium Meeting, December 14-15, 2010

Page 31: Representation and Use of Clinical Data in Immport

HLA Genetics Consortium Meeting, December 14-15, 2010

Page 32: Representation and Use of Clinical Data in Immport

HLA Genetics Consortium Meeting, December 14-15, 2010

Page 33: Representation and Use of Clinical Data in Immport

HLA Genetics Consortium Meeting, December 14-15, 2010

Page 34: Representation and Use of Clinical Data in Immport

HLA Genetics Consortium Meeting, December 14-15, 2010

Page 35: Representation and Use of Clinical Data in Immport

HLA Genetics Consortium Meeting, December 14-15, 2010

Page 36: Representation and Use of Clinical Data in Immport

HLA Genetics Consortium Meeting, December 14-15, 2010

Page 37: Representation and Use of Clinical Data in Immport

HLA Genetics Consortium Meeting, December 14-15, 2010

Page 38: Representation and Use of Clinical Data in Immport

HLA Genetics Consortium Meeting, December 14-15, 2010

Page 39: Representation and Use of Clinical Data in Immport

HLA Genetics Consortium Meeting, December 14-15, 2010

Tube 33 Population 2

Lymphocyte Region

Page 40: Representation and Use of Clinical Data in Immport

HLA Genetics Consortium Meeting, December 14-15, 2010

ImmPort Clinical Data

ImmPort currently has a wealth of experimental data in the personal workspaces of investigators

Use of data in the Semi-Public Workspaces offers an exciting ability to collaborate, generate hypotheses, and share data

Structured data models are necessary to use complex clinical research data

Mapping data to make it useful for translational and clinical studies is time-consuming – work with us early!